Beyond the Guidelines: Evaluating BI-RADS 3 Lesions in a High-Suspicion Breast Cancer Population: Outcomes and Clinical Implications.
OBJECTIVE BI-RADS category 3 lesions are typically benign (<2% malignancy risk), managed with follow-up imaging, but their upgrade to BI-RADS 4 may indicate malignancy, particularly in high-risk patients. This study evaluates malignancy risk and predictors among BI-RADS 3 lesions upgraded to BI-RADS 4 in a cohort with...